Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00104598 · ClinicalTrials.gov registry record · NA
Framing Messages for Smoking Cessation With Bupropion - 6
A NA study, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 252
- Enrollment target
NCT00104598: Completed NA study, sponsored by Yale University.
NCT00104598 is a NA study that has completed, run by Yale University. The registered enrollment target is 252 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00104598, a NA study, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 252 participants
- Enrollment target
Study Summary
This is a randomized study of message framing in individuals beginning a smoking cessation program utilizing bupropion SR and brief counseling, videos, and pamphlets.
Interventions
- DRUG Bupropion
- BEHAVIORAL Smoking Abstinence Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2000-09 |
| Est. Completion | 2006-12 |
| Phase | NA |
What the finished NCT00104598 record still lists
NCT00104598 is an interventional study that assigns participants to a tested intervention. The registered 252 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 2 interventions - of which Bupropion is the first listed.
NCT00104598 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00104598 about?
NCT00104598 is a clinical study titled "Framing Messages for Smoking Cessation With Bupropion - 6". This is a randomized study of message framing in individuals beginning a smoking cessation program utilizing bupropion SR and brief counseling, videos, and pamphlets.
What is the current status of trial NCT00104598?
This trial is currently completed. It is a NA study. The enrollment target is 252 participants. The study started on 2000-09. Estimated completion is 2006-12.
What interventions are being tested in trial NCT00104598?
The interventions under investigation include: Bupropion (DRUG), Smoking Abstinence Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT00104598?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00104598's enrollment target sits among peer trials
252 407th of 2000 higher than 1,591 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02314988 · 252 participants · Phase 2
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
- NCT03941756 · 252 participants · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- NCT05219617 · 252 participants · Phase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- NCT05384158 · 252 participants · NA
Valuation in Depressed Mood, Anhedonia, and Anxiety
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia